Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic delay in histiocytic neoplasms and its association with local resource deprivation.

Haematologica·2026
Same author

Impact of Cortisol Circadian Rhythm on Psychological Well-Being in Treated Cushing Syndrome: A Cross-Sectional Study.

The Journal of clinical endocrinology and metabolism·2026
Same author

Autoimmune Rondeau.

JAMA·2026
Same author

Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairment.

Neuro-oncology practice·2026
Same author

Real-world multi-institution analysis of tarlatamab in patients with small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Reducing the Rate of Treatment Disruptions Through a Digital Structured Exercise and Mind-Body Program During Systemic Cancer Therapy: A Secondary Analysis of a Randomized Clinical Trial.

Cancers·2026
Same journal

Error in Visual Abstract.

JAMA network open·2026
Same journal

The Promise of Artificial Intelligence-Powered Speech Biomarkers in Psychiatry.

JAMA network open·2026
Same journal

Diet and Dementia Risk in Individuals With Prevalent Neuropathology.

JAMA network open·2026
Same journal

Medical Record Abstraction for Quality Improvement in Sepsis Care Using Artificial Intelligence: A Cluster Randomized Trial.

JAMA network open·2026
Same journal

Needs and Perspectives on Upper Limb Prostheses Among Children and Adolescents With Upper Limb Differences.

JAMA network open·2026
Same journal

Sex-Based Disparities in Health Care Access and Utilization Among Patients With Atrial Fibrillation.

JAMA network open·2026
See all related articles
  1. Home
  2. Enhanced Telehealth In Prostate Cancer.
  1. Home
  2. Enhanced Telehealth In Prostate Cancer.

Related Experiment Video

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Enhanced Telehealth in Prostate Cancer.

Erin M Bange1, Anne S Reiner2, Christine Liebertz3

  • 1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

JAMA Network Open
|June 9, 2026

View abstract on PubMed

Summary
This summary is machine-generated.

Enhanced telehealth is a feasible model for prostate cancer care, improving patient convenience and satisfaction. This approach combines remote monitoring and in-home services, supporting further development for efficient patient-centered oncology services.

More Related Videos

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

Related Experiment Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

Area of Science:

  • Oncology
  • Health Services Research
  • Digital Health

Background:

  • Prostate cancer treatment, particularly androgen deprivation therapy (ADT), often necessitates frequent in-person visits.
  • These frequent visits create significant burdens for patients, including travel, financial costs, and time away from daily life.
  • Enhanced telehealth offers a patient-centered and efficient alternative to traditional in-person care models.

Purpose of the Study:

  • To evaluate the feasibility and implementation context of an enhanced telehealth program for prostate cancer patients.
  • To assess patient and clinician satisfaction with various components of enhanced telehealth.
  • To gather data supporting the further development of telehealth solutions in oncology.

Main Methods:

  • A multiphase quality improvement study involving adult prostate cancer patients on ADT.
  • Phase 1: Semistructured interviews with stakeholders to identify implementation considerations.
  • Phase 2: Piloted enhanced telehealth including remote blood pressure (BP) monitoring, mobile phlebotomy, and at-home injections.
  • Main Results:

    • High patient-level completion rates were observed for remote BP monitoring (91.9%), home phlebotomy (96.3%), and at-home injections (90.0%).
    • Visit-level completion rates exceeded 65% for all components, with telehealth and phlebotomy showing over 90% completion.
    • Patients and clinicians reported high satisfaction and rated all enhanced telehealth components as acceptable, appropriate, and feasible.

    Conclusions:

    • Enhanced telehealth, incorporating remote monitoring and in-home services, is a feasible and well-accepted care delivery model for prostate cancer patients.
    • The study demonstrated high completion and satisfaction rates, supporting the integration of enhanced telehealth into routine oncology practice.
    • These findings advocate for the continued development and implementation of enhanced telehealth to improve patient-centered cancer care.